UK life sciences are stronger in the EU, says BioIndustry Association
25 March 2016
The UK life sciences sector is growing and continually evolving as one of the key high-tech, high-growth sectors that the UK’s economy needs. We work in a global environment so we need to be international in outlook and scope. As the UK looks towards the EU referendum on June 23rd, it is important to highlight the success the sector has experienced as part of the largest global market by volume.
RUSNANO’s Profit More Than Doubled for the Second Consecutive Year
24 March 2016
RUSNANO Group consisting of JSC RUSNANO and its consolidated subsidiaries (including RUSNANO MC LLC) announced its 2015 financial performance in accordance with International Financial Reporting Standards (IFRS) confirmed by an independent auditor.
23andMe broadens R&D footprint with new genetic service through Apple's ResearchKit
24 March 2016
23andMe is rolling out a product that runs through Apple's ($AAPL) ResearchKit to collect genetic information from study participants. The move plays into the company's broader focus on research, as 23andMe looks to R&D to recover from a falling out with the FDA over direct-to-consumer genetic testing.
Here's a welcome new-drug side effect: Physician access is on the rise, CMI/Compas' survey shows
24 March 2016
The doctor is ready to see you, pharma. CMI/Compas' annual Media Vitals study out today forecasts increased access to physicians for pharma companies this year.
NHS launches digital health tech accelerator in London
24 March 2016
The U.K.'s National Health Service doesn't have the reputation of being particularly technology savvy. In fact, it's had a long and public struggle--that's not yet complete--to get electronic medical records into place. But NHS England CEO Simon Stevens, who rejoined the agency in early 2014, is making a big push for the more effective integration of tech. And the former UnitedHealth Group exec is trying to loop business into early efforts to integrate more technology to promote healthcare efficiency.
Study finds mindfulness meditation offers relief for low-back pain
23 March 2016
Mindfulness based stress reduction (MBSR) and cognitive-behavioral therapy (CBT) may prove more effective than usual treatment in alleviating chronic low-back pain, according to a new study funded by the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health.
Nasdaq exec says biotechs prime Asian unicorns for listings
23 March 2016
With Hong Kong-based Hutchison China Meditech (Chi-Med) listing shares on the Nasdaq this week, a top executive at the exchange says more biotechs in Asia should head his way to become the next unicorns from the region.
2020 guidance offers foresight for transition from NDA to BLA
22 March 2016
A proposed guidance intended to help sponsors of proteins see their way forward as the FDA transitions the drugs from the 505 path of small-molecule products to 351 biologics license applications (BLAs) could trip up a lot of development plans and open newer drugs to competition much earlier than expected.
Scientists discover non-opioid pain pathway in the brain
22 March 2016
Results from a new study, funded in part by the National Center for Complementary and Integrative Health, demonstrate that mindfulness meditation works on a different pain pathway in the brain than opioid pain relievers. The researchers noted that because opioid and non-opioid mechanisms of pain relief interact synergistically, the results of this study suggest that combining mindfulness-based and pharmacologic/nonpharmacologic pain-relieving approaches that rely on opioid signaling may be particularly effective in treating pain.
Early-stage biotech funding at risk from drying well
22 March 2016
Funding streams for early-stage biopharma and med tech research dwindled in 2015, as investors shifted their support to bigger companies--potentially cutting off the lifeblood for future life sciences R&D.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024